Biocracked
Approach: conceptual metaphor. Palette: D, bold color field.

A single steel dumbbell sits in the center of a saturated tomato-red seamless backdrop. A thick, taut rope of frayed tan fibers wraps around its handle, and a few strands are visibly thinning and unraveling at one end while the rest stay dense and intact, standing for muscle being preserved while weight drops. Shot at a low three-quarter angle with a shallow depth of field, so the knurled grip texture is crisp and the background melts into smooth red. Hard, directional studio light from the upper left casts a sharp, short shadow on the glossy red surface. One thin electric green cable tie is cinched around the rope. The mood is punchy, tense and editorial, with no people and no text.
Peptides

Menene Za a Hada da Tirzepinide Don Kula da Tsoka? Kure Sun Ba da Shaida

Nova Chen · · 5 min read

Gargadi: duk abin da ke ƙasa ya samo ne daga ƙure masu kiba na mata, ba daga mutane ba. Wannan ba tsarin da za a kwaikwayi ba ne, sai dai alama ce da za a yi la’akari da ita.

Tirzepinide na narkar da kitse kamar mannewa. Abin damuwa shi ne menene zai bace tare da kitse – wato tsoka. Wani sabon bincike a The Journal of Physiology ya gwada abin da ke faruwa idan an haɗa maganin da hanyoyi biyu na rayuwa: cin abinci a lokaci mai iyaka (TRF) da horon ƙarfi. Sakamakon ya nuna rarraba aikin da aka samu.

Abin da masu binciken suka yi

Ƙungiyar da Macêdo da abokan aikinsa suka jagoranta – tare da manyan marubuta Ropelle da Pauli – ta yi amfani da ƙure Swiss na mata. An sa su suyi kiba cikin makonni 10, sannan aka ba su tirzepinide na tsawon makonni 8.

  • Tirzepinide: ƙwayar magani mai haɗa GIP/GLP‑1, ana ba shi ƙasa da fata a tsarin ƙara ƙima.
  • Time‑restricted feeding (TRF): awa 12 a rana na cin abinci kawai.
  • Resistance training: hawa matakala a ranakun da aka keɓe.

Masu binciken sun bi diddigin nauyin jiki, adadin kalori da yadda jiki ke amfani da su. Sun yi gwaje‑gwajen juriya ga sukari da insulin, suka auna kitsen jiki, tsoka da hanta, sannan suka duba kitse a hanta ta hanyar histology da kuma tantance ƙwayoyin gina kitse.

Mai da hankali kan mata yana da muhimmanci; har yanzu ba a san yadda tirzepinide ke hulɗa da abinci da motsa jiki a maza ba, musamman a hawan hanta.

Sakamako 1: Haɗin ya hanzarta ragin nauyi da kitse

Tirzepinide kaɗai ya rage ƙaruwa a nauyin jiki da kuma inganta yanayin ƙarancin makamashi. Lokacin da aka haɗa shi da TRF da horon ƙarfi, ragin nauyi ya zama mai sauri. Horon ƙarfi ya kawo nauyin da ya kusan kai matsayin ƙungiyar kulawa.

Ragin nauyin ya zo da ƙananan kwayoyin kitse da ƙananan sel‑sel na kitse (karancin girman sel). Marubutan sun fassara wannan a matsayin gyaran tsarin kitsen jiki, wato canjin tsari da raguwa.

Sakamako 2: Horon ƙarfi ya kare tsoka

Wannan shine abin da duk wanda ke damuwa da rasa ƙarfi zai so ji. Horon ƙarfi ya ƙara ƙarfin ƙashi da yawan tsoka. Marubutan sun nuna cewa horon ne ya kiyaye tsoka yayin da tirzepinide ke haifar da ragin nauyi.

Wannan sakamakon ya dace da tsammanin masana motsa jiki, amma yana da amfani a ga shi a yanayin da ake amfani da tirzepinide. A wannan binciken, kariyar tsoka ta samo ne daga horon, ba daga lokacin cin abinci ba.

Sakamako 3: TRF tare da tirzepinide ya inganta sarrafa sukari

Tirzepinide da TRF – ko da an haɗa da horon ƙarfi ko a’a – ya inganta juriya ga sukari a ƙure. Marubutan sun kammala da cewa haɗin dabaru ya fi inganta juriya ga insulin a jiki gaba ɗaya fiye da kowanne tsari guda.

Takaitaccen jadawali

Hanyar Abinda aka samu a ƙure
Tirzepinide Rage nauyi, yanayin ƙarancin makamashi
+ TRF Ingantacciyar juriya ga sukari
+ Horon ƙarfi Ƙarin tsoka, ƙarfin ƙashi mafi girma, nauyi ya kusan kai matsayin kulawa
Duka uku Ragin nauyi mafi sauri, tsarin metabolism mafi ƙarfi

Abinda bai canza ba: Hanta ba ta nuna bambanci

Duk matakan sun rage tara kitse a hanta da fitar da ƙwayoyin gina kitse, kuma haɗin ba su ƙara wani fa'ida a hanta ba. Tirzepinide kaɗai ya riga ya yi aiki a can. Idan kana fatan haɗin zai sa hanta mai kitse ta tsarkaka da sauri fiye da maganin kaɗai, wannan binciken ba ya nuna hakan.

Abubuwan da za a yi la’akari da su (tare da iyakoki)

Matsakaicin kima (dose): wannan takarda ba ta ba da shawarar kima ga mutane ba. Tsarin ƙara ƙima da aka yi amfani da shi a ƙure ba za a iya fassara shi kai tsaye zuwa mutane ba. Kowane ƙima ga mutum ya kamata ya fito daga likita.

Lokaci (timing): TRF a wannan bincike ya kasance awa 12 a rana. Kure na dare ne, kuma metabolism dinsu ya bambanta da na mutane, don haka kar a ɗauka cewa wannan jadawalin zai yi aiki a mutane. Horon ƙarfi ya kasance hawa matakala a ranakun da aka keɓe, wanda zai iya zama kama da zaman horon ƙarfi a kowane rana biyu. Wannan wani tsari ne, ba umarni ba.

Waɗanda za su iya amfana: mutanen da ke karɓar tirzepinide kuma suke son kare tsoka tare da damar yin horo lafiya. Binciken yana tallafawa ra'ayin cewa horon ƙarfi ya dace a haɗe da maganin. Ba ya tabbatar da irin wannan sakamako a mutane.

Waɗanda ya kamata su nisanta ko su nemi shawarwarin likita da farko:

  • Kowa da ba ya samun kulawar likita kan tirzepinide. Kada a yi amfani da wannan bincike a matsayin dalilin fara magani.
  • Mutanen da ke da tarihin matsalolin cin abinci, waɗanda ya kamata su yi hankali da kowane irin tsarin lokaci na cin abinci (TRF).
  • Mutanen da ke kan magungunan rage sukari, domin canza lokacin cin abinci tare da su na iya tasiri kan sukari a jini; ya kamata a tattauna da likita.
  • Kowa da rauni ko yanayi na lafiya da ke takaita motsa jiki, ya kamata su nemi shawarwarin da ya dace.

Abubuwan da ba za a watsar da su ba

  • Kure, ba mutane. Kure Swiss na mata da ke hawa matakala suna da bambanci sosai da mutane a fannin halayen jiki, abinci da sarrafa magani.
  • Jinsi ɗaya. Mayar da hankali kan mata ya cika wani gibi, amma binciken ba ya ba da bayani kan yadda maza za su amsa.
  • Gajere kuma bincike na farko. Makonni takwas na magani ba za su iya ba da cikakken haske kan sakamakon dogon lokaci ko dawowar nauyi bayan daina magani ba.
  • Mekanik. Takaitaccen bayani ya ƙunshi sakamakon kamar nauyin jiki, kitsen jiki, yawan tsoka da juriya ga sukari. Ba ya bayyana ainihin dalilin da yasa haɗin ke aiki.

Karshe

A ƙure masu kiba na mata, tirzepinide ya yi aiki, amma ƙarin abubuwan sun tsara ingancin sakamakon. Horon ƙarfi ya kiyaye tsoka da ƙarfin ƙashi, TRF ya taimaka wajen sarrafa sukari, kuma haɗin duka uku ya haifar da ragin nauyi mafi sauri. Gwaje‑gwajen mutane za su nuna ko wannan haɗin zai tsaya. Har sai haka, saƙon aikace‑aikace shine cewa ɗaga ƙasa tare da maganin incretin yana da ma'ana, kuma ya kamata a tattauna da likitan ku.

Wannan labarin na bayani ne kawai, ba shawarar likita ba.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 3, the human outcome, in palette B, warm.

Low three-quarter rear angle, shot with a 50mm lens at shallow depth of field. A middle-aged person's forearm and hand grip a loaded barbell mid-deadlift, the tendons and the muscle of the forearm clearly defined, with chalk dust hanging in the air. Their face is out of frame. The setting is a plain home garage gym with a rubber floor and a rack softly blurred in the background. Low golden-hour sunlight comes through an open roll-up door and rakes across the skin and the knurled steel, casting long warm shadows. Amber, copper and honey tones dominate, with matte black plates for contrast. A tiny electric green silicone wristband or a small green pen injector resting on a nearby shelf adds a subtle accent. The mood is determined, quiet and hopeful.
metabolism

Game da Tirzepatide? Ɗaga Nauyi Ya Ceton 1.1 kg na Tsokoki

BY REX MERIDIAN ·

Tirzepatide na iya rage fiye da 22 kg a cikin makonni 40, amma yana sa a rasa ƙwayar jiki da ƙarfi. Gwajin bazuwar da ya kunshi mutane 120 ya nuna cewa, idan aka yi horon ƙarfi sau uku a mako, asarar kitse ta kasance iri ɗaya, amma an ceton kusan 1.1 kg na ƙwayar jiki mara mai kuma ƙarfi ya ƙaru.

Approach: 3, the human outcome, here as an animal-science moment. Palette: C, natural.

An old female lab mouse with slightly greying, ruffled fur sits upright on a researcher's open gloved palm, photographed at eye level in a close side-on view with a shallow depth of field. Behind it, a softly blurred animal facility window pours in real morning daylight, giving the scene a pale green-grey and warm-wood setting. The nitrile glove is a vivid electric green (#00e676), the single saturated accent. The mouse's whiskers and pink ears catch the light, and the researcher's white coat sleeve is just visible. Tones are natural: skin, soft cream bedding, sage walls. The mood is calm, careful and quietly hopeful, and it conveys age and care rather than drama. The image has no text, no labels and no readable writing.
longevity

Abin da ke cikin Ozempic ya tsawaita rayuwar berayen da suka tsufa – Ga dalilin

BY DR. SYNAPSE ·

Semaglutide, sinadarin da ke cikin Ozempic da Wegovy, ya tsawaita rayuwar berayen mata tsofaffi a wani sabon bincike da aka wallafa a *Nature* daga UC Berkeley. An ba su maganin ne a lokacin da suke da watanni 20, inda aka ga alamun rage tsufa da inganta aikin jiki. A gwajin beraye, semaglutide ya ba da sakamako mafi kyau fiye da rage kalori (CR) a kan sha’awar abinci, ƙwaƙwalwa da sarrafa sukari. Amma wannan bincike ya ƙunshi berayen mata ne kawai, ba ya nufin amfani ga mutane. Ga abin da sakamakon ke nuni da shi da abin da ba ya nuni ba.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Shin Ozempic da Mounjaro Suna Haifar da Tunani na Kashe Kai? Abin da Bincike 20 Ya Gano

BY DR. SYNAPSE ·

Shin magungunan Ozempic da Mounjaro na ƙara haɗarin damuwa, fargaba ko tunani na kashe kai? Bincike mai tsari da aka wallafa a *Rambam Maimonides Medical Journal* ya nuna cewa hujjojin da suka fi ƙarfi ba su tabbatar da wannan haɗari ba. Gwaje‑gwajen da aka yi da tsarin bazuwar ba su nuna ƙaruwa a haɗarin tunani na kashe kai, damuwa ko fargaba ga masu amfani da semaglutide ko tirzepatide ba. Sai dai akwai buƙatar ci gaba da sa ido ga waɗanda ke da tarihin cutar kwakwalwa.

Approach: Macro science. Palette: D, bold color field.

Extreme close-up microscopy-style image of a dense cluster of oval, rod-shaped bacteria with a slightly mucous, glossy membrane texture, shot from a shallow top-down angle with a razor-thin focal plane. Most of the colony sits in the sharp center, softening into creamy blur at the edges. The cells are warm ivory with subtle translucent depth, resting on a saturated tomato-red backdrop. A scattering of sparser, isolated cells on one side suggests "low baseline" and hints at the subgroup story. One or two cells carry a faint electric green (#00e676) fluorescent rim glow. Lighting is soft, directional studio light with gentle specular highlights on the cell walls and clean shadows in warm red tones. Mood: curious, precise, quietly skeptical, with a vivid but grounded look. No text and no blue cast.
supplements

Akkermansia Ta Gaza Cimma Babban Manufa—Sai a Cikin Mutanen da Ba Su Da Ita

BY NOVA CHEN ·

Bakteriyar hanji da ake talla a matsayin “kwararren ƙarfafa GLP‑1 na halitta” an gwada ta a kan mutane 142 a yanayi na sirri ba tare da sanin wanene ke shan maganin ba, kuma ba ta kai ga babban manufa na inganta fahimtar insulin ba. Sai dai bayan nazarin ƙarin bayanai an ga karuwar GLP‑1 bayan shan sukari, kuma mutanen da suka fara da ƙarancin Akkermansia sun samu ingantacciyar fahimtar insulin da ƙasa da kitse a jiki. Sakamakon ƙananan ƙungiyoyi suna ba da sabuwar fahimta, suna kusa da matakin muhimmi, kuma an samo su daga binciken da masana'antu suka haɗa. Ga abin da bayanai ke nuna, abin da ba su nuna ba, da kuma waɗanda za su iya sha'awa.

This page is available in